Annual Information Update
July 18 2007 - 2:01AM
UK Regulatory
RNS Number:4098A
Celsis International PLC
18 July 2007
CELSIS INTERNATIONAL PLC
("Celsis", "the Company" or "the Group")
ANNUAL INFORMATION UPDATE
18 July 2007: Celsis International plc, the life sciences products and
laboratory services company, is pleased to provide an annual information update,
in accordance with the requirements of the Prospectus Rule 5.2. This update
refers to information that has been published or made available by the Company
to the public over the twelve months preceding this announcement. To avoid a
statement of unnecessary length information is referred to in this update rather
than included in full.
In accordance with Rule 5.2.7 of the Prospectus Rules, the information referred
to in this update was up to date at the time the information was published but
some information may now be out of date. This annual information update does
not constitute an offer of securities addressed to any person and should not be
relied on by any person.
1. Announcements made via the Regulatory News Service ("RNS"), a Regulatory
Information Service ("RIS").
Date of Publication Regulatory Headline
6 June 2006 Notice of results
14 June 2006 Final results
14 June 2006 Acquisition
16 June 2006 Doc re. acquisition
7 July 2006 Annual report and accounts
7 July 2006 Annual information update
11 July 2006 EGM statement
26 July 2006 AGM statement
26 July 2006 Result of AGM
31 July 2006 Share options
1 August 2006 Holding in company
30 August 2006 Holding in company BARC
11 September 2006 Holding in company BARC
19 September 2006 Goodwill tax benefit on acquisition of IVT
28 September 2006 Preclose trading update
25 October 2006 Notice of results
2 November 2006 Holding in company BARC
8 November 2006 Interim results
17 November 2006 Director/pdmr shareholding
22 November 2006 Holding in company BARC
15 December 2006 Holding in company BARC
24 January 2007 Treasury stock
1 February 2007 Total voting rights
5 February 2007 Holding in company BARC
6 March 2007 Holding in company
9 March 2007 Holding in company
16 March 2007 Holding in company BARC
20 March 2007 Holding in company HBOS
28 March 2007 Trading update
19 April 2007 Holding in company HBOS
15 May 2007 Appointments
16 May 2007 Notice of results
20 June 2007 Final results
5 July 2007 Holding in company BARC
9 July 2007 Annual report and accounts
Copies of all announcements can be obtained from the Regulatory News Service of
the London Stock Exchange.
2. Documents filed at Companies House
The documents listed below were filed with the Registrar of Companies in England
and Wales on or around the dates indicated. Copies of these documents can be
obtained from Companies House.
Date Document type Description
26 June 2006 363 Annual Return
18 July 2006 287 Change in situation or address of registered office
27 July 2006 AA Report and Accounts
2 July 2007 288a Appointment of new Non Executive Director, Peter Jensen
2 July 2007 288a Appointment of new Non Executive Director Nicholas Badman
3. Documents sent to Shareholders
The documents listed below have been despatched by the Company to holders of its
securities on or around the following dates.
Date Description
5 July 2007 2007 Annual Report and Accounts
5 July 2007 Notice of Annual General Meeting
28 November 2006 2006 Interim Report
4. Documents submitted to the UK Listing Authority
Copies of the following documents have been submitted to the UK Listing
Authority for inspection at their Document Viewing Facility on or around the
following dates and can be obtained from the Company Secretary, Celsis
International plc, 1010 Cambourne Business Park, Cambourne, Cambridge, CB23 6DP.
Date Description
5 July 2007 2007 Annual Report and Accounts
5 July 2007 Notice of Annual General Meeting
28 November 2006 2006 Interim Report
Enquiries:
Celsis International plc Tel: 01223 598 428
Christian Madrolle, Company Secretary
Jenny Parsons, Corporate Communications
Financial Dynamics Tel: 020 7831 3113
Ben Atwell
David Yates
Notes to editors
Celsis International plc
Celsis International plc is a world leading provider of innovative life science
products and laboratory services to the pharmaceutical, biopharmaceutical, and
consumer products industries through its three business areas; rapid detection,
analytical and drug development services and ADME-Tox in vitro technologies.
The company is listed on the London Stock Exchange (CEL.L).
Each division of Celsis International plc has the capacity to deliver
substantial time and cost savings to its customers, in addition to ensuring
product quality and safety for consumers. Using proprietary technology, the
Celsis Rapid Detection division provides diagnostic systems for the rapid
detection of contamination. These systems provide significant economic value by
reducing the time it takes to test and release raw materials, in process and
finished goods to market. Celsis Analytical Services division provides cost
effective outsourced laboratory testing services to pharmaceutical and
biopharmaceutical companies. Its comprehensive service offerings include a full
spectrum of laboratory services from drug development and discovery to
analytical chemistry and biological sciences to stability storage and testing.
Celsis In Vitro Technologies (Celsis IVT) supplies in vitro testing products to
the pharmaceutical and biotechnology industries. IVT's in vitro products screen
drug compounds early in the discovery process, thereby reducing the time and
cost of drug development.
Further information can be found on its website at www.celsis.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUDDLFFDDBBBBX
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024